Q-omics provides the consensus-scored CTBP2P10 profile across patient tissues and cancer cell-line models. CTBP2P10 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in ESCA. Additionally, CTBP2P10 RNA expression shows 2,310 significant gene co-expression associations, with the highest sampling consensus in KIRC. Together, these results highlight ESCA, and KIRC as cancer lineages where CTBP2P10 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.